This inventor holds 3 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1995-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1998
Title: The Innovative Contributions of Peter J. Bugelski
Introduction
Peter J. Bugelski, based in Philadelphia, PA, is a notable inventor recognized for his impactful work in the field of pharmaceutical innovations. With a total of three patents to his name, Bugelski has made significant strides in medical treatments, particularly against opportunistic infections and hyperlipidemia.
Latest Patents
Bugelski's latest patents include:
1. Methods of treating opportunistic infections with azaspiranes.
2. Methods for the treatment of hyperlipidemia using azaspiranes.
These patents showcase his commitment to improving medical therapies and addressing critical health issues.
Career Highlights
Throughout his career, Peter J. Bugelski has been affiliated with SmithKline Beecham Corporation, a prominent player in the pharmaceutical industry. His work has contributed to the company's reputation for innovation and excellence in developing medicinal solutions.
Collaborations
In addition to his individual achievements, Bugelski has collaborated with esteemed colleagues, including Wiliam D. Kerns and Alison Mary Badger. These partnerships have likely fostered an environment of creativity and shared knowledge, further enhancing the quality of his inventions.
Conclusion
Peter J. Bugelski stands out as a remarkable inventor whose contributions are shaping the future of medical treatments. With a focus on azaspiranes, his innovative approach is helping to address significant health challenges, making a lasting impact in the pharmaceutical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile